TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.

Simon J Crabb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.